Publications: Dr Adam Brentnall
Manchanda R, Wei X, Sun L, Slade E, Fierheller C, Oxley S, Kalra A, Sia J et al.
(
2024
)
.
Cost-effectiveness analysis of cancer susceptibility gene-specific prevention strategies for ovarian and breast cancer
.
Gynecologic Oncology
.
vol.
190
,
s159
-
s160
.
Sasieni P, Brentnall AR
(
2024
)
.
More Efficient Smaller Multi-Cancer Screening Trials
.
Journal of the National Cancer Institute
Hill H, Roadevin C, Duffy S, Mandrik O, Brentnall A
(
2024
)
.
Cost-Effectiveness of AI for Risk-Stratified Breast Cancer Screening
.
JAMA Network Open
vol.
7
,
(
9
)
Faheem M, Tam HZ, Nojoum M, Suaris T, Jahan N, Lloyd T, Johnson L, Aggarwal S et al.
(
2024
)
.
Role of Supplemental Breast MRI in Screening Women with Mammographically Dense Breasts: A Systematic Review and Meta-analysis
.
Journal of Breast Imaging
vol.
6
,
(
4
)
355
-
377
.
Slade E, Berg L, Dworzynski K, Manchanda R
(
2024
)
.
Ovarian cancer: identifying and managing familial and genetic risk—summary of new NICE guidance
.
BMJq807
-
q807
.
Law R, Krupa K, Brentnall A, Tam HZ, Rusby JE
(
2024
)
.
CANCER-RELATED ANXIETY AND PERCEIVED BREAST CANCER RISK IN PARTICIPANTS OF A RANDOMISED PILOT STUDY OF LIFESTYLE INTERVENTION TO REDUCE BREAST CANCER RISK (PIONEER)
.
European Journal of Surgical Oncology
vol.
50
,
Law R, Krupa K, Brentnall A, Tam HZ, Rusby JE
(
2024
)
.
Pilot of lifestyle intervention to reduce breast cancer risk (PIONEER): A randomised study
.
European Journal of Surgical Oncology
vol.
50
,
Rebolj M, Brentnall AR, Cuschieri K
(
2024
)
.
Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening
.
British journal of cancer
vol.
130
,
(
11
)
1733
-
1743
.
Gilham C, Nedjai B, Scibior‐Bentkowska D, Reuter C, Banwait R, Brentnall AR, Cuzick J, Peto J et al.
(
2024
)
.
Long‐term prediction by DNA methylation of high‐grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort
.
International Journal of Cancer
vol.
155
,
(
1
)
81
-
92
.
Manchanda R, Evans DG, Antoniou AC, Brentnall A
(
2024
)
.
Penetrance estimates of hereditary cancers in a population setting using UK Biobank data
.
BJC Reports
vol.
2
,
(
1
)
Wei X, Sun L, Slade E, Fierheller C, Oxley S, Kalra A, Sia J, Sideris M et al.
(
2024
)
.
443 Cost-effectiveness analysis of cancer susceptibility gene-specific prevention strategies for ovarian and breast cancer
.
Conference:
Oral Sessionsa40
-
a41
.
Wei X, Sun L, Slade E, Fierheller CT, Oxley S, Kalra A, Sia J, Sideris M et al.
(
2024
)
.
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer
.
JAMA Network Open
vol.
7
,
(
2
)
Santeramo R, Damiani C, Wei J, Montana G, Brentnall AR
(
2024
)
.
Are better AI algorithms for breast cancer detection also better at predicting risk? A paired case–control study
.
Breast Cancer Research
vol.
26
,
(
1
)
Pegington M, Zhen Tam H, Brentnall A, Sestak I, Adams J, Blake GM, Gareth Evans D, Howell A et al.
(
2024
)
.
Body composition changes during breast cancer preventive treatment with anastrozole: Findings from the IBIS-II trial
.
Preventive medicine reports
vol.
38
,
Brentnall AR, Cuschieri K, Sargent A, Berkhof J, Rebolj M
(
2023
)
.
Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening
.
Journal of clinical epidemiology
vol.
166
,
Cuzick J, Chu K, Keevil B, Brentnall AR, Howell A, Zdenkowski N, Bonanni B, Loibl S et al.
(
2023
)
.
Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial
.
The Lancet Oncology
vol.
25
,
(
1
)
108
-
116
.
Wei X, Sun L, Slade E, Oxley S, Kalra A, Sia J, Sideris M, Fierheller C et al.
(
2023
)
.
EE675 Cost-Effectiveness Analysis of Cancer Susceptibility Gene-Specific Prevention and Surveillance Strategies for Ovarian and Breast Cancer
.
Value in Health
.
vol.
26
,
s183
-
s184
.
Brentnall AR, Atakpa EC, Hill H, Santeramo R, Damiani C, Cuzick J, Montana G, Duffy SW
(
2023
)
.
An optimization framework to guide the choice of thresholds for risk-based cancer screening
.
npj Digital Medicine
vol.
6
,
(
1
)
Atakpa EC, Buist DSM, Aiello Bowles EJ, Cuzick J, Brentnall AR
(
2023
)
.
Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort study
.
Breast cancer research : BCR
vol.
25
,
(
1
)
Swanton C, Bachtiar V, Mathews C, Brentnall AR, Lowenhoff I, Waller J, Bomb M, McPhail S et al.
(
2023
)
.
1239P NHS-Galleri trial enrolment approaches and participant sociodemographic diversity
.
Annals of Oncology
vol.
34
,
Roberts E, van Veen EM, Byers H, Barnett-Griness O, Gronich N, Lejbkowicz F, Pinchev M, Smith MJ et al.
(
2023
)
.
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent
.
Genetics in medicine : official journal of the American College of Medical Genetics
vol.
25
,
(
10
)
Brentnall AR, Mathews C, Beare S, Ching J, Sleeth M, Sasieni P
(
2023
)
.
Dynamic data-enabled stratified sampling for trial invitations with application in NHS-Galleri
.
Clin Trials
vol.
20
,
(
4
)
425
-
433
.
Shepherd JM, Ross J, Anton L, Rourke C, Brentnall AR, Tarning J, White NJ, Thiemermann C et al.
(
2023
)
.
Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial
.
Intensive care medicine
vol.
49
,
(
8
)
922
-
933
.
Damiani C, Kalliatakis G, Sreenivas M, Al-Attar M, Rose J, Pudney C, Lane EF, Cuzick J et al.
(
2023
)
.
Evaluation of an AI Model to Assess Future Breast Cancer Risk
.
Radiology
vol.
307
,
(
5
)
Faheem M, Thompson EW, Aggarwal S, Ullah Z, Brentnall A
(
2023
)
.
Role of breast MRI in screening women with dense breasts: A systematic review
.
European Journal of Surgical Oncology
vol.
49
,
(
5
)
Gareth Evans D, McWilliams L, Astley S, Brentnall AR, Cuzick J, Dobrashian R, Duffy SW, Gorman LS et al.
(
2023
)
.
Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
.
British Journal of Cancer
vol.
128
,
(
11
)
2140
-
2140
.
Roberts E, van Veen EM, Byers H, Barnett-Griness O, Gronich N, Lejbkowicz F, Pinchev M, Smith MJ et al.
(
2023
)
.
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent
.
Genetics in medicine : official journal of the American College of Medical Genetics
vol.
25
,
(
9
)
Wei X, Oxley S, Sideris M, Kalra A, Brentnall A, Sun L, Yang L, Legood R et al.
(
2023
)
.
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis
.
American journal of obstetrics and gynecology
vol.
229
,
(
4
)
388
-
409.e4
.
Gareth Evans D, McWilliams L, Astley S, Brentnall AR, Cuzick J, Dobrashian R, Duffy SW, Gorman LS et al.
(
2023
)
.
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
.
British Journal of Cancer
vol.
128
,
(
11
)
2063
-
2071
.
Atakpa EC, Cuzick J, Duffy SW, Evans DG, Howell SJ, Brentnall AR
(
2023
)
.
Abstract PD14-01: PD14-01 A model to assess the utility of risk-based screening algorithms
.
Cancer Research
vol.
83
,
(
5_Supplement
)
Oxley S, Kalra A, Sideris M, Itzkowitz N, Evans O, Atakpa EC, Brentnall AR, Dworschak N et al.
(
2023
)
.
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK
.
Cancers
vol.
15
,
(
4
)
Paige JS, Lee CI, Wang P-C, Hsu W, Brentnall AR, Hoyt AC, Naeim A, Elmore JG
(
2023
)
.
Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman
.
Journal of General Internal Medicine
vol.
38
,
(
11
)
2584
-
2592
.
Pegington M, Harvie M, Harkness EF, Brentnall A, Malcomson L, Southworth J, Fox J, Howell A et al.
(
2023
)
.
Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester
.
BMC women's health
vol.
23
,
(
1
)
Doorbar JA, Mathews CS, Denton K, Rebolj M, Brentnall AR
(
2022
)
.
Supporting the implementation of new healthcare technologies by investigating generalisability of pilot studies using area-level statistics
.
BMC health services research
vol.
22
,
(
1
)
Crocker-Buque T, Myles J, Brentnall A, Gabe R, Duffy S, Williams S, Tiberi S
(
2022
)
.
Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admission
.
PLOS ONE
vol.
17
,
(
10
)
Brentnall AR, Rebolj M
(
2022
)
.
Comments on: "Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening"
.
International journal of cancer
vol.
151
,
(
3
)
481
-
483
.
Evans DGR, van Veen EM, Harkness EF, Brentnall AR, Astley SM, Byers H, Woodward ER, Sampson S et al.
(
2022
)
.
Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel
.
Genetics in Medicine
vol.
24
,
(
7
)
1485
-
1494
.
Atakpa EC, Thorat MA, Cuzick J, Brentnall AR
(
2021
)
.
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review
.
Cochrane Database of Systematic Reviews
vol.
2021
,
(
10
)
Evans DG, van Veen EM, Byers H, Roberts E, Howell A, Howell SJ, Harkness EF, Brentnall A et al.
(
2021
)
.
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
.
International Journal of Cancer
vol.
150
,
(
1
)
73
-
79
.
Atakpa EC, Brentnall AR, Astley S, Cuzick J, Evans DG, Warren RML, Howell A, Harvie M
(
2021
)
.
The Relationship between Body Mass Index and Mammographic Density during a Premenopausal Weight Loss Intervention Study
.
Cancers
vol.
13
,
(
13
)
Leventea E, Harkness EF, Brentnall AR, Howell A, Evans DG, Harvie M
(
2021
)
.
Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
.
Cancers
vol.
13
,
(
11
)
Crocker-Buque T, Williams S, Brentnall AR, Gabe R, Duffy S, Prowle JR, Orkin C, Kunst H et al.
(
2021
)
.
The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London
.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
vol.
25
,
(
5
)
358
-
366
.
Belaya JA, Zakharova NA, Brentnall AR
(
2021
)
.
Реализация маммографического скрининга в Ханты-Мансийском автономном округе – Югре
.
Tumors of female reproductive system
vol.
16
,
(
3
)
32
-
36
.
Brentnall AR, Duffy SW
(
2020
)
.
Calculating, Using and Improving Individual Breast Cancer Risk Estimates
.
Breast MRI for High-risk Screening
,
Springer Nature
Ramírez AT, Sánchez GI, Nedjai B, Agudelo MC, Brentnall A, Cuschieri K, Castañeda KM, Cuzick J et al.
(
2020
)
.
Effective methylation triage of HPV positive women with abnormal cytology in a middle-
2 income country
.
International Journal of Cancer
Brentnall AR, Warren R, Harkness EF, Astley SM, Wiseman J, Fox J, Fox L, Eriksson M et al.
(
2020
)
.
Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years
.
Breast Cancer Research
vol.
22
,
(
1
)
Manchanda R, Sun L, Patel S, Evans O, Wilschut J, De Freitas Lopes AC, Gaba F, Brentnall A et al.
(
2020
)
.
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
.
Cancers
vol.
12
,
(
7
)
French DP, Astley S, Brentnall AR, Cuzick J, Dobrashian R, Duffy SW, Gorman LS, Harkness EF et al.
(
2020
)
.
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)
.
BMC Cancer
vol.
20
,
(
1
)
Brentnall AR, van Veen EM, Harkness EF, Rafiq S, Byers H, Astley SM, Sampson S, Howell A et al.
(
2020
)
.
A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density
.
Int J Cancer
vol.
146
,
(
8
)
2122
-
2129
.
Renehan AG, Pegington M, Harvie MN, Sperrin M, Astley SM, Brentnall AR, Howell A, Cuzick J et al.
(
2020
)
.
Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom)
.
British Journal of Cancer
vol.
122
,
(
10
)
1552
-
1561
.
Brentnall AR, Cuzick J
(
2020
)
.
Risk Models for Breast Cancer and Their Validation
.
Statistical science : a review journal of the Institute of Mathematical Statistics
vol.
35
,
(
1
)
14
-
30
.
Law RS, Pitches C, Krupa K, Brentnall A, Rusby J
(
2020
)
.
Abstract OT3-15-01: Pilot of lifestyle InterventiON to reducE brEast cancer Risk (PIONEER): A randomised study
.
Cancer Research
vol.
80
,
(
4_Supplement
)
Wang C, Brentnall AR, Mainprize J, Yaffe M, Cuzick J, Harvey JA
(
2020
)
.
External validation of a mammographic texture marker for breast cancer risk in a case–control study
.
Journal of Medical Imaging
vol.
7
,
(
1
)
014003
-
014003
.
Moore KM, Desai A, de Luxán Delgado B, Trabulo SMD, Reader C, Brown NF, Murray ER, Brentnall A et al.
(
2020
)
.
Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus
.
Theranostics
vol.
10
,
(
7
)
2930
-
2942
.
Bright CJ, Brentnall AR, Wooldrage K, Myles J, Sasieni P, Duffy SW
(
2020
)
.
Errors in determination of net survival: cause-specific and relative survival settings
.
British Journal of Cancer
Sun L, Brentnall A, Patel S, Buist D, Bowles E, Evans D, Eccles D, Hopper J et al.
(
2019
)
.
Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis
.
International Journal of Gynecological Cancer
.
Conference:
Oral Communication 4 – Gynaecological Cancer
vol.
29
,
Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J et al.
(
2019
)
.
A Cost-effectiveness Analysis of Multigene Testing for All Patients with Breast Cancer
.
JAMA Oncology
Manchanda R, Sun L, Patel S, Wilschut J, de Freitas ALC, Brentnall A, Duffy S, Cui B et al.
(
2019
)
.
10 Global economic evaluation of population-based BRCA1/BRCA2 mutation testing
.
International Journal of Gynecological Cancer
.
Conference:
Plenary sessions
vol.
29
,
Sun L, Brentnall A, Patel S, Buist SM D, Bowles JA E, Evans R DG, Eccles D, Hopper J et al.
(
2019
)
.
66 Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis
.
Regional plenaryA36.2
-
A37
.
Rebolj M, Brentnall AR, Mathews C, Denton K, Holbrook M, Levine T, Sargent A, Smith J et al.
(
2019
)
.
16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
.
British Journal of Cancer
vol.
121
,
(
6
)
455
-
463
.
Reader CS, Vallath S, Steele CW, Haider S, Brentnall A, Desai A, Moore KM, Jamieson NB et al.
(
2019
)
.
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy
.
The Journal of Pathology
vol.
249
,
(
3
)
332
-
342
.
Brentnall AR, Cohn WF, Knaus WA, Yaffe MJ, Cuzick J, Harvey JA
(
2019
)
.
A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model
.
Journal of Breast Imaging
vol.
1
,
(
2
)
99
-
106
.
Cuzick J, Brentnall A
(
2019
)
.
Commentary on Terry et al., 10-Year Performance of Four Models of Breast Cancer Risk: A Validation Study. Lancet Oncol. 2019;20(4):504-17
.
Med One
vol.
4
,
(
2
)
Evans DGR, Harkness EF, Brentnall AR, van Veen EM, Astley SM, Byers H, Sampson S, Southworth J et al.
(
2019
)
.
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
.
Breast Cancer Research and Treatment
vol.
176
,
(
1
)
141
-
148
.
Escala-Garcia M, Guo Q, Dörk T, Canisius S, Keeman R, Dennis J, Beesley J, Lecarpentier J et al.
(
2019
)
.
Genome-wide association study of germline variants and breast cancer-specific mortality
.
British Journal of Cancer
vol.
120
,
(
6
)
647
-
657
.
Evans DG, Thomas S, Caunt J, Burch A, Brentnall AR, Roberts L, Howell A, Wilson M et al.
(
2019
)
.
Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35-39 at Increased Familial Risk of Breast Cancer
.
EClinicalMedicine
vol.
7
,
39
-
46
.
Ionescu GV, Fergie M, Berks M, Harkness EF, Hulleman J, Brentnall AR, Cuzick J, Evans DG et al.
(
2019
)
.
Prediction of reader estimates of mammographic density using convolutional neural networks
.
Journal of Medical Imaging
vol.
6
,
(
3
)
031405
-
031405
.
Cook DA, Krajden M, Brentnall AR, Gondara L, Chan T, Law JH, Smith LW, van Niekerk DJ et al.
(
2018
)
.
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
.
International Journal of Cancer
vol.
144
,
(
10
)
2587
-
2595
.
Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen T-H et al.
(
2018
)
.
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
.
American Journal of Human Genetics
vol.
104
,
(
1
)
21
-
34
.
Brentnall AR, Buist DSM, Cuzick J
(
2018
)
.
Competing Risks for a Diagnosis of Invasive Breast Cancer-Reply
.
JAMA Oncol
Rebolj M, Brentnall A, Duffy SW
(
2018
)
.
Reply to ‘Comment on ‘Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis”
.
British Journal of Cancer
vol.
119
,
(
11
)
1444
-
1444
.
Zakharova NA, Brentnall AR, Belaya J, Bilan E
(
2018
)
.
1595P 10-year results of the breast cancer screening program in Khanty-Mansiysk state region Ugra
.
Annals of Oncology
vol.
29
,
Brentnall AR, Cuzick J, Buist DSM, Bowles EJA
(
2018
)
.
Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density
.
JAMA oncology
vol.
4
,
(
9
)
Buus R, Yeo B, Brentnall AR, Klintman M, Cheang MCU, Khabra K, Sestak I, Gao Q et al.
(
2018
)
.
Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer
.
Breast Cancer Research
vol.
20
,
(
1
)
Atakpa EC, Thorat MA, Cuzick J, Brentnall AR
(
2018
)
.
Mammographic density, endocrine therapy and breast cancer risk: A prognostic and predictive biomarker review
.
Cochrane Database of Systematic Reviews
vol.
2018
,
(
8
)
Ionescu GV, Fergie M, Berks M, Harkness EF, Hulleman J, Brentnall AR, Cuzick J, Evans DG et al.
(
2018
)
.
Using a convolutional neural network to predict readers' estimates of mammographic density for breast cancer risk assessment
.
Progress in Biomedical Optics and Imaging - Proceedings of SPIE
.
Conference:
14th International Workshop on Breast Imaging (IWBI 2018)
(
Atlanta, Georgia, United States
)
from:
11/07/2018
to:
08/07/2018
,
vol.
10718
,
Wang C, Brentnall AR, Cuzick J, Harkness EF, Evans DG, Astley S
(
2018
)
.
Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds
.
Breast Cancer Research
vol.
20
,
(
1
)
Rebolj M, Assi V, Brentnall A, Parmar D, Duffy SW
(
2018
)
.
Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis
.
British journal of cancer
vol.
118
,
(
12
)
1559
-
1570
.
van Veen EM, Brentnall AR, Byers H, Harkness EF, Astley SM, Sampson S, Howell A, Newman WG et al.
(
2018
)
.
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction
.
JAMA oncology
vol.
4
,
(
4
)
476
-
482
.
Astley SM, Harkness EF, Sergeant JC, WARWICK J, Stavrinos P, Warren R, Wilson M, Beetles U et al.
(
2018
)
.
A comparison of five methods of measuring mammographic density: a case-control study
.
Breast Cancer Research
Evans DG, Brentnall AR, Harvie M, Astley S, Harkness EF, Stavrinos P, Donnelly LS, Sampson S et al.
(
2018
)
.
Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK
.
BMC public health
vol.
18
,
(
1
)
van Veen EM, Harkness EF, Brentnall AR, Astley SM, Sampson S, Howell A, Newman WG, Cuzick J et al.
(
2018
)
.
Improving breast cancer risk prediction by combining 18 SNPs, mammographic density and the Tyrer-Cuzick model
.
EUROPEAN JOURNAL OF HUMAN GENETICS
.
vol.
26
,
681
-
681
.
Brentnall AR, Cheng RCH
(
2017
)
.
Some effects of aircraft arrival sequence algorithms
.
Journal of the Operational Research Society
vol.
60
,
(
7
)
962
-
972
.
Brentnall A
(
2017
)
.
Discrete-Event System Simulation (International Edition)
.
Journal of Simulation
vol.
1
,
(
3
)
223
-
223
.
Cuzick J, Brentnall A, Dowsett M
(
2017
)
.
SNPs for breast cancer risk assessment
.
Oncotarget
vol.
8
,
(
59
)
99211
-
99212
.
Howell A, Ashcroft L, Fallowfield L, Eccles DM, Eeles RA, Ward A, Brentnall AR, Dowsett M et al.
(
2017
)
.
RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer
.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
vol.
27
,
(
1
)
58
-
66
.
Wang C, Brentnall AR, Cuzick J, Harkness EF, Evans DG, Astley S
(
2017
)
.
A novel and fully automated mammographic texture analysis for risk prediction: results from two case-control studies
.
Breast cancer research : BCR
vol.
19
,
(
1
)
Vasiljević N, Carter PD, Reuter C, Warman R, Brentnall AR, Carton JR, Cuzick J, Lorincz AT
(
2017
)
.
Role of quantitative p16<sup>INK4A</sup> mRNA assay and digital reading of p16<sup>INK4A</sup> immunostained sections in diagnosis of cervical intraepithelial neoplasia
.
International journal of cancer
vol.
141
,
(
4
)
829
-
836
.
Brentnall AR, Sasieni P, Cuzick J
(
2017
)
.
Estimating efficacy in trials with selective crossover
.
Statistics in medicine
vol.
36
,
(
15
)
2333
-
2346
.
Brentnall AR, Duffy SW, Cuzick J
(
2017
)
.
Breast-Cancer Tumor Size and Screening Effectiveness
.
vol.
376
,
is.
1
,
pp.
94
-
94
.
Brentnall AR, Cuzick J
(
2016
)
.
Use of the concordance index for predictors of censored survival data
.
Statistical Methods in Medical Research
vol.
27
,
(
8
)
2359
-
2373
.
Cuzick J, Brentnall AR, Segal C, Byers H, Reuter C, Detre S, Lopez-Knowles E, Sestak I et al.
(
2016
)
.
Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials
.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
vol.
35
,
(
7
)
743
-
750
.
Evans DG, Brentnall A, Byers H, Harkness E, Stavrinos P, Howell A, FH-risk study Group, Newman WG et al.
(
2016
)
.
The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study
.
Journal of medical genetics
vol.
54
,
(
2
)
111
-
113
.
Sasieni P, Brentnall AR
(
2016
)
.
On standardized relative survival
.
Biometrics
vol.
73
,
(
2
)
473
-
482
.
Evans DG, Astley S, Stavrinos P, Harkness E, Donnelly LS, Dawe S, Jacob I, Harvie M et al.
(
2016
)
.
Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics:a dual cohort study
.
Programme Grants for Applied Research
vol.
4
,
(
11
)
1
-
210
.
Brentnall AR, Cuzick J, Byers H, Segal C, Reuter C, Detre S, Sestak I, Howell A et al.
(
2016
)
.
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials
.
Breast cancer research and treatment
vol.
158
,
(
3
)
591
-
596
.
Astley S, Harkness E, Sergeant J, Stavrinos P, Warren R, Wilson M, Brentnall A, Cuzick J et al.
(
2016
)
.
13 Proffered Paper: A comparison of four methods of mammographic density measurement in the UK Predicting Risk Of Cancer At Screening (PROCAS) study – on behalf of the PROCAS Study team
.
European Journal of Cancer
vol.
61
,
Evans DGR, Donnelly LS, Harkness EF, Astley SM, Stavrinos P, Dawe S, Watterson D, Fox L et al.
(
2016
)
.
Breast cancer risk feedback to women in the UK NHS breast screening population
.
British Journal of Cancer
vol.
114
,
(
9
)
1045
-
1052
.
Evans D, Astley S, Brentnall A, Howell A, Cuzick J
(
2016
)
.
Abstract PD1-07: Mammographic density and SNPs add to Tyrer-Cuzick and Gail model breast cancer risk in a UK screening cohort
.
Cancer Research
.
vol.
76
,
Lorincz AT, Brentnall AR, Scibior‐Bentkowska D, Reuter C, Banwait R, Cadman L, Austin J, Cuzick J et al.
(
2016
)
.
Validation of a DNA methylation HPV triage classifier in a screening sample
.
International Journal of Cancer
vol.
138
,
(
11
)
2745
-
2751
.
Astley S, Harkness E, Sergeant J, Stavrinos P, Warren R, Wilson M, Brentnall A, Cuzick J et al.
(
2016
)
.
A comparison of four methods of mammographic density measurement in the UK Predicting Risk Of Cancer At Screening (PROCAS) study - on behalf of the PROCAS Study team
.
EUROPEAN JOURNAL OF CANCER
.
vol.
61
,
S6
-
S6
.
Brentnall AR, Harkness EF, Astley SM, Donnelly LS, Stavrinos P, Sampson S, Fox L, Sergeant JC et al.
(
2015
)
.
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort
.
Breast Cancer Research
vol.
17
,
(
1
)
Brentnall AR, Cuzick J
(
2015
)
.
Atypical hyperplasia of the breast
.
New England Journal of Medicine
vol.
372
,
(
13
)
1269
-
1270
.
Brentnall AR, Cuzick J, Field J, Duffy SW
(
2015
)
.
A concordance index for matched case-control studies with applications in cancer risk
.
Stat Med
vol.
34
,
(
3
)
396
-
405
.
Brentnall AR, Cuzick J
(
2015
)
.
Atypical Hyperplasia of the Breast
.
NEW ENGLAND JOURNAL OF MEDICINE
vol.
372
,
(
13
)
1269
-
1270
.
Brentnall AR, Vasiljevic N, Scibior-Bentkowska D, Cadman L, Austin J, Cuzick J, Lorincz AT
(
2015
)
.
HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifier
.
Cancer Biomarkers
vol.
15
,
(
5
)
669
-
675
.
Assi V, Massat NJ, Thomas S, MacKay J, Warwick J, Kataoka M, Warsi I, Brentnall A et al.
(
2014
)
.
A case‐control study to assess the impact of mammographic density on breast cancer risk in women aged 40–49 at intermediate familial risk
.
International Journal of Cancer
vol.
136
,
(
10
)
2378
-
2387
.
Warwick J, Birke H, Stone J, Warren RM, Pinney E, Brentnall AR, Duffy SW, Howell A et al.
(
2014
)
.
Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I
.
Breast Cancer Research
vol.
16
,
(
5
)
Evans DG, Brentnall AR, Harvie M, Dawe S, Sergeant JC, Stavrinos P, Astley S, Wilson M et al.
(
2014
)
.
Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention
.
Cancer Prev Res (Phila)
vol.
7
,
(
10
)
993
-
1001
.
Brentnall AR, Vasiljević N, Scibior-Bentkowska D, Cadman L, Austin J, Szarewski A, Cuzick J, Lorincz AT
(
2014
)
.
A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes
.
Int J Cancer
vol.
135
,
(
6
)
1425
-
1432
.
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.
(
2014
)
.
Therapeutic targeting of integrin αvβ6 in breast cancer
.
J Natl Cancer Inst
vol.
106
,
(
8
)
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.
(
2014
)
.
Abstract B046: Therapeutic targeting of integrin αvβ6 in high-risk breast cancer
.
Molecular Cancer Research
vol.
11
,
(
10_Supplement
)
b046
-
b046
.
Cuzick JM, Brentnall A, Segal C, Sestak I, Kealy R, Howell A, Powles TJ, Orr N et al.
(
2014
)
.
Use of a SNP panel to refine risk estimates in women at high risk of breast cancer: Results from two randomized tamoxifen prevention trials
.
Journal of Clinical Oncology
.
vol.
32
,
1519
-
1519
.
Evans G, Stavrinos P, Dawe S, Harvie M, Wilson M, Maxwell A, Brentnall A, Cuzick J et al.
(
2014
)
.
8LBA Assessing individual breast cancer risk within the UK National Health Service Breast Screening Programme: First prospective results from PROCAS
.
European Journal of Cancer
.
vol.
50
,
s3
-
s4
.
Vasiljević N, Scibior-Bentkowska D, Brentnall A, Cuzick J, Lorincz A
(
2014
)
.
A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers
.
J Clin Virol
vol.
59
,
(
3
)
161
-
166
.
Vasiljević N, Scibior-Bentkowska D, Brentnall AR, Cuzick J, Lorincz AT
(
2014
)
.
Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women
.
Gynecol Oncol
vol.
132
,
(
3
)
709
-
714
.
Brentnall AR, Evans DG, Cuzick J
(
2014
)
.
Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK
.
Br J Cancer
vol.
110
,
(
3
)
827
-
828
.
Ho-Yen CM, Green AR, Rakha EA, Brentnall AR, Ellis IO, Kermorgant S, Jones JL
(
2014
)
.
C-Met in invasive breast cancer: is there a relationship with the basal-like subtype?
.
Cancer
vol.
120
,
(
2
)
163
-
171
.
Evans DGR, Ingham S, Dawe S, Roberts L, Lalloo F, Brentnall AR, Stavrinos P, Howell A
(
2014
)
.
Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme
.
FAMILIAL CANCER
vol.
13
,
(
2
)
189
-
196
.
Sasieni PD, Brentnall AR
(
2014
)
.
Survival Analysis
.
Handbook of Epidemiology
,
Springer Nature
Lorincz AT, Brentnall AR, Vasiljević N, Scibior-Bentkowska D, Castanon A, Fiander A, Powell N, Tristram A et al.
(
2013
)
.
HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology
.
Int J Cancer
vol.
133
,
(
3
)
637
-
644
.
Adam RB, D GE, Jack C
(
2013
)
.
Value of Phenotypic and Single-Nucleotide Polymorphism Panel Markers in Predicting the Risk of Breast Cancer
.
Journal of Genetic Syndromes & Gene Therapy
vol.
04
,
(
11
)
Yang Z, Brentnall AR, Cuzick J, Sasieni P
(
2012
)
.
Estimating the Complier Average Causal Effect for Exponential Survival in the Presence of Mid-Trial Switching
.
International Journal of Statistics in Medical Research
vol.
1
,
(
2
)
84
-
90
.
Brentnall AR, Duffy SW, Baio G, Raine R
(
2012
)
.
Strategy for power calculation for interactions: application to a trial of interventions to improve uptake of bowel cancer screening
.
Contemp Clin Trials
vol.
33
,
(
1
)
213
-
217
.
Allen MD, Vaziri R, Green M, Chelala C, Brentnall AR, Dreger S, Vallath S, Nitch-Smith H et al.
(
2011
)
.
Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion
.
J Pathol
vol.
223
,
(
5
)
646
-
658
.
Brentnall AR, Crowder MJ, Hand DJ
(
2011
)
.
Approximate repeated-measures shrinkage
.
COMPUT STAT DATA AN
vol.
55
,
(
2
)
1150
-
1159
.
Brentnall AR, Duffy SW, Crowder MJ, Gillan MGC, Astley SM, Wallis MG, James J, Boggis CRM et al.
(
2011
)
.
A METHOD FOR EXPLORATORY REPEATED-MEASURES ANALYSIS APPLIED TO A BREAST-CANCER SCREENING STUDY
.
ANNALS OF APPLIED STATISTICS
vol.
5
,
(
4
)
2448
-
2469
.
Vasiljević N, Wu K, Brentnall AR, Kim DC, Thorat MA, Kudahetti SC, Mao X, Xue L et al.
(
2011
)
.
Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing
.
Dis Markers
vol.
30
,
(
4
)
151
-
161
.
Duffy SW, Mackay J, Thomas S, Anderson E, Evans DG, Fielder H, Fox R, Gray J et al.
(
2010
)
.
Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study
.
LANCET ONCOL
vol.
11
,
(
12
)
1127
-
1134
.
Brentnall AR, Crowder MJ, Hand DJ
(
2010
)
.
Predictive-sequential forecasting system development for cash machine stocking
.
INT J FORECASTING
vol.
26
,
(
4
)
764
-
776
.
James JJ, Gilbert FJ, Wallis MG, Gillan MGC, Astley SM, Boggis CRM, Agbaje OF, Brentnall AR et al.
(
2010
)
.
Mammographic Features of Breast Cancers at Single Reading with Computer-aided Detection and at Double Reading in a Large Multicenter Prospective Trial of Computer-aided Detection: CADET II
.
Radiology
vol.
256
,
(
2
)
379
-
386
.
Brentnall AR, Crowder MJ, Hand DJ
(
2010
)
.
Predicting the amount individuals withdraw at cash machines using a random effects multinomial model
.
STAT MODEL
vol.
10
,
(
2
)
197
-
214
.
Brentnall AR, Crowder MJ, Hand DJ
(
2008
)
.
A Statistical Model for the Temporal Pattern of Individual Automated Teller Machine Withdrawals
.
Journal of the Royal Statistical Society Series C (Applied Statistics)
vol.
57
,
(
1
)
43
-
59
.
Brentnall AR, Cheng RC, Drew A
(
2004
)
.
Statistical analysis of an air traffic control problem
.
International Journal of Simulation: Systems, Science and Technology
vol.
5
,
(
1-2
)
26
-
32
.